RheumaGen CEO Richard Freed Presented at 2024 CBSA Biotech Symposium

Written By Soraya Rudofsky

RheumaGen CEO Richard Freed was invited to speak on the “Transformative Innovations in Colorado Advancing Regenerative Medicine” panel at the 2024 Biotech Symposium: Innovations in Regenerative Medicine on Tuesday, April 23, 2024. Freed highlighted the shifting landscape in regenerative medicine, saying, “We can use words like ‘cures’ now. We can see the future, and it’s really exciting for all of us.”

Learn more here.

Soraya Rudofsky
Previous

RheumaGen Featured on in Fitzsimons Innovation Community “Innovation Spotlight”
Next

RheumaGen Awarded Grant from Colorado Office of Economic Development